|
|
Volumn 15, Issue 3, 2014, Pages 380-394
|
|
Molecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and future
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ANIMAL;
CARCINOMA, HEPATOCELLULAR;
DRUG EFFECTS;
HUMAN;
LIVER NEOPLASMS;
MOLECULARLY TARGETED THERAPY;
MULTIMODALITY CANCER THERAPY;
NEOVASCULARIZATION, PATHOLOGIC;
PATHOLOGY;
RISK FACTOR;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
COMBINED MODALITY THERAPY;
HUMANS;
LIVER NEOPLASMS;
MOLECULAR TARGETED THERAPY;
NEOVASCULARIZATION, PATHOLOGIC;
RISK FACTORS;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
|
|
EID: 85027922441
PISSN: None
EISSN: 15346277
Source Type: Journal
DOI: 10.1007/s11864-014-0291-7 Document Type: Review |
|
Times cited : (20)
|
|
References (0)
|